Information
Organization's Own Description:
Coquí RadioPharmaceuticals, Corp. (Coquí Pharma) is a company whose mission is to create a commercially scalable reliable supply of medical diagnostic and therapeutic radioisotopes in the United States. Around the world only a small number of facilities have the capacity for the commercial production of radioisotopes. Yet the United States, the largest market for medical radioisotopes, has no domestic supply and in turn relies on imports from Canada, Europe and elsewhere.
Essential to nuclear medicine radioisotopes are applied in the diagnosis and treatment of diseases. Its uses span a wide range of diagnostic and treatment applications including brain, heart, lung, liver, renal, oncologic, and muscle skeletal diseases. Of all the medical radioisotopes Molybdenum 99 (Moly) is used for over 80% of procedures. Lasting only 66 hours after production Moly cannot be stockpiled and presents unique distribution challenges when imported into United States. In recent years Moly shortages deprived patients of lifesaving diagnostics and treatment.
read more
Subscribers to LegiStorm Pro see the full address information for Coqui Radiopharmaceuticals Corp..
Click here to see more LegiStorm Pro benefits and subscribe, or
log in
to your Pro account.